Lissa Padnick‐Silver

1.1k total citations
37 papers, 808 citations indexed

About

Lissa Padnick‐Silver is a scholar working on Nephrology, Ophthalmology and Surgery. According to data from OpenAlex, Lissa Padnick‐Silver has authored 37 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 17 papers in Ophthalmology and 12 papers in Surgery. Recurrent topics in Lissa Padnick‐Silver's work include Gout, Hyperuricemia, Uric Acid (18 papers), Case Reports on Hematomas (10 papers) and Retinal Diseases and Treatments (8 papers). Lissa Padnick‐Silver is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (18 papers), Case Reports on Hematomas (10 papers) and Retinal Diseases and Treatments (8 papers). Lissa Padnick‐Silver collaborates with scholars based in United States, Switzerland and New Zealand. Lissa Padnick‐Silver's co-authors include Robert A. Linsenmeier, Marian S. Macsai, Brian LaMoreaux, Jennifer J. Kang‐Mieler, Megan Francis‐Sedlak, Elizabeth A. Giuliano, Robert J. Holt, Bruno Machado Fontes, Kimberly Cockerham and Aaron Weinberg and has published in prestigious journals such as Ophthalmology, Annals of the Rheumatic Diseases and Medicine.

In The Last Decade

Lissa Padnick‐Silver

33 papers receiving 787 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lissa Padnick‐Silver United States 16 510 345 253 100 97 37 808
Tarun Sharma United States 18 499 1.0× 303 0.9× 436 1.7× 26 0.3× 38 0.4× 80 1.1k
Dong‐Jin Oh South Korea 15 409 0.8× 173 0.5× 249 1.0× 62 0.6× 56 0.6× 27 701
Giacinto Triolo Italy 20 1.0k 2.0× 691 2.0× 319 1.3× 29 0.3× 47 0.5× 44 1.2k
Evangelia E. Tsironi Greece 18 446 0.9× 227 0.7× 132 0.5× 16 0.2× 60 0.6× 62 856
M. Kurz–Levin Switzerland 11 479 0.9× 257 0.7× 234 0.9× 12 0.1× 20 0.2× 27 764
A Weinberger Germany 16 665 1.3× 453 1.3× 294 1.2× 9 0.1× 22 0.2× 44 917
Divakar Gupta United States 15 523 1.0× 339 1.0× 170 0.7× 6 0.1× 61 0.6× 41 905
Birgitta Bauer Sweden 16 393 0.8× 149 0.4× 274 1.1× 19 0.2× 10 0.1× 32 718
Hiroki Ueno Japan 13 212 0.4× 393 1.1× 135 0.5× 19 0.2× 18 0.2× 22 689
Yanling Wang China 12 292 0.6× 224 0.6× 114 0.5× 7 0.1× 24 0.2× 52 506

Countries citing papers authored by Lissa Padnick‐Silver

Since Specialization
Citations

This map shows the geographic impact of Lissa Padnick‐Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lissa Padnick‐Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lissa Padnick‐Silver more than expected).

Fields of papers citing papers by Lissa Padnick‐Silver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lissa Padnick‐Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lissa Padnick‐Silver. The network helps show where Lissa Padnick‐Silver may publish in the future.

Co-authorship network of co-authors of Lissa Padnick‐Silver

This figure shows the co-authorship network connecting the top 25 collaborators of Lissa Padnick‐Silver. A scholar is included among the top collaborators of Lissa Padnick‐Silver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lissa Padnick‐Silver. Lissa Padnick‐Silver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Troum, O., Mai Duong, K. Obermeyer, Lissa Padnick‐Silver, & Brian LaMoreaux. (2025). Treatment-emergent major adverse cardiovascular and thromboembolic events were infrequent during clinical trials of pegloticase. Lara D. Veeken. 64(6). 3328–3333.
2.
3.
Stern, Leonard, Richard J. Johnson, Lissa Padnick‐Silver, et al.. (2024). Prevalence and Influence of Gout in Patients with Advanced Chronic Kidney Disease: Findings of a Large Retrospective Chart Review. MDPI (MDPI AG). 2(1). 77–85. 4 indexed citations
4.
5.
Mudano, Amy S., Fenglong Xie, Jingyi Zhang, et al.. (2024). Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation. Arthritis Research & Therapy. 26(1). 86–86.
6.
7.
Padnick‐Silver, Lissa, et al.. (2023). Comparison Between Early-Onset and Common Gout: A Systematic Literature Review. Rheumatology and Therapy. 10(4). 809–823. 6 indexed citations
8.
9.
10.
Padnick‐Silver, Lissa, et al.. (2022). Effect of Leflunomide on Pegloticase Response Rate in Patients with Uncontrolled Gout: A Retrospective Study. Rheumatology and Therapy. 9(2). 555–563. 10 indexed citations
11.
Schlesinger, Naomi, Lissa Padnick‐Silver, & Brian LaMoreaux. (2022). Enhancing the Response Rate to Recombinant Uricases in Patients with Gout. BioDrugs. 36(2). 95–103. 15 indexed citations
12.
Padnick‐Silver, Lissa, et al.. (2022). Community Practice Experiences with a Variety of Immunomodulatory Agents Co-Administered with Pegloticase for the Treatment of Uncontrolled Gout. Rheumatology and Therapy. 9(6). 1549–1558. 4 indexed citations
13.
14.
Patel, Vishal K., et al.. (2021). Characteristics of Diabetic and Nondiabetic Patients With Thyroid Eye Disease in the United States: A Claims-Based Analysis. Endocrine Practice. 28(2). 159–164. 7 indexed citations
15.
Keenan, Robert T., et al.. (2021). The effect of immunomodulators on the efficacy and tolerability of pegloticase: a systematic review. Seminars in Arthritis and Rheumatism. 51(2). 347–352. 34 indexed citations
16.
Francis‐Sedlak, Megan, Brian LaMoreaux, Lissa Padnick‐Silver, Robert J. Holt, & Alfonso E. Bello. (2020). Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study. Rheumatology and Therapy. 8(1). 183–197. 16 indexed citations
17.
Padnick‐Silver, Lissa, et al.. (2012). Incidence of Presumed Iatrogenic Graft Failure in Descemet Stripping Automated Endothelial Keratoplasty. Cornea. 31(8). 872–875. 8 indexed citations
18.
Padnick‐Silver, Lissa, et al.. (2011). PILOT STUDY FOR THE DETECTION OF EARLY EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH OPTICAL COHERENCE TOMOGRAPHY. Retina. 32(6). 1045–1056. 25 indexed citations
19.
Budzynski, Ewa, N.D. Wangsa–Wirawan, Lissa Padnick‐Silver, Diane L. Hatchell, & Robert A. Linsenmeier. (2005). Intraretinal pH in Diabetic Cats. Current Eye Research. 30(3). 229–240. 21 indexed citations
20.
Padnick‐Silver, Lissa. (2005). Effect of Hypoxemia and Hyperglycemia on pH in the Intact Cat Retina. Archives of Ophthalmology. 123(12). 1684–1684. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tarun Sharma Breakdown of academic impact, for papers by Dong‐Jin Oh Breakdown of academic impact, for papers by Giacinto Triolo Breakdown of academic impact, for papers by Evangelia E. Tsironi Breakdown of academic impact, for papers by M. Kurz–Levin Breakdown of academic impact, for papers by A Weinberger Breakdown of academic impact, for papers by Divakar Gupta Breakdown of academic impact, for papers by Birgitta Bauer Breakdown of academic impact, for papers by Hiroki Ueno Breakdown of academic impact, for papers by Yanling Wang
Rankless by CCL
2026